Aug 10, 2026 08:00AM
Jun 30, 2026 08:00AM
Jun 30, 2026 08:00AM
Jun 18, 2026 06:47AM
Jun 12, 2026 08:00AM
Jun 12, 2026 08:00AM
Jun 1, 2026 07:31AM Cogent (COGT) Reiterated at Buy by Stifel After ASCO Presentation on Bezuclastinib
Jun 1, 2026 06:57AM
May 30, 2026 08:00AM
May 30, 2026 08:00AM
May 28, 2026 08:01AM
May 28, 2026 08:00AM
May 5, 2026 08:00AM
Apr 2, 2026 06:45AM H.C. Wainwright Reiterates Buy Rating on Cogent (COGT)
Apr 1, 2026 08:02AM
Apr 1, 2026 08:00AM
Mar 16, 2026 09:57AM
Mar 16, 2026 08:02AM
Mar 16, 2026 08:00AM
Feb 17, 2026 08:00AM
Feb 10, 2026 08:00AM Cogent Biosciences Announces Multiple SUMMIT Posters at the 2026 AAAAI Annual Meeting
Jan 26, 2026 08:02AM
Jan 26, 2026 08:00AM
Jan 20, 2026 08:02AM
Jan 20, 2026 08:00AM
Jan 14, 2026 06:54AM
Jan 12, 2026 03:47PM
Jan 12, 2026 08:07AM Cogent Biosciences outlines 2026 milestones for bezuclastinib drug applications
Jan 12, 2026 08:00AM
Jan 7, 2026 12:41AM
Jan 6, 2026 06:42AM
Dec 30, 2025 08:02AM
Dec 30, 2025 08:00AM
Dec 8, 2025 07:31AM
Dec 8, 2025 07:30AM Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
Dec 8, 2025 02:54AM
Dec 6, 2025 09:30AM
Nov 10, 2025 01:18PM
Nov 10, 2025 07:00AM
Nov 10, 2025 07:00AM
Nov 3, 2025 09:01AM
Oct 24, 2025 12:30PM Cogent Biosciences presents KRAS inhibitor data at cancer conference
Oct 24, 2025 12:30PM
Oct 24, 2025 08:29AM
Oct 20, 2025 08:32AM
Oct 20, 2025 08:32AM
Aug 5, 2025 08:00AM
Jul 7, 2025 07:07AM
Jul 7, 2025 07:06AM Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Adv
Jan 2, 2025 12:51PM

328,094 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All